Navigation Links
United States Patent Office Issues Decision in Re-examination Proceedings
Date:7/24/2009

ST. PETERSBURG, Fla., July 24 /PRNewswire-FirstCall/ -- Smith & Nephew Inc.'s Advanced Wound Management division (LSE: SN; NYSE: SNN) announced that the United States Patent and Trademark Office (Patent Office) has issued actions in re-examination proceedings involving three of the negative pressure wound therapy (NPWT) patents licensed to Kinetic Concepts, Inc. (NYSE: KCI), confirming the patentability of the re-examined claims. The re-examination proceedings are still pending, and Smith & Nephew intends to pursue its appeal rights.

These actions from the Patent Office do not affect Smith & Nephew's ability to defend the pending U.S. district court lawsuit, and do not affect Smith & Nephew's ability to continue to sell any of its NPWT products in the U.S., including foam products.

"Smith and Nephew entered the NPWT marketplace to meet the clear demand for options that enable clinicians to use NPWT with their own best clinical judgment," said Tom Dugan, President, North America, Advanced Wound Management. "We have been confident in our IP position from the onset, and convinced that competition in this marketplace would bring value to customers and ultimately help physicians and their patients. Our position has been validated by courts in Germany and the United Kingdom, which revoked KCI's European counterpart patent in lawsuits KCI brought against Smith & Nephew in those countries, and we remain confident of our position as we approach pending litigation in the U.S. and Australia."

For more information regarding Smith & Nephew, please visit our Web site at http://www.smith-nephew.com

About Smith & Nephew

Smith & Nephew is a global medical technology business, specializing in Orthopaedics, including Reconstruction, Trauma and Clinical Therapies, Endoscopy and Advanced Wound Management. Smith & Nephew is a global leader in arthroscopy and advanced wound management and is one of the leading global orthopaedics companies.

Smith & Nephew is dedicated to helping improve people's lives. The Company prides itself on the strength of its relationships with its surgeons and professional healthcare customers, with whom its name is synonymous with high standards of performance, innovation and trust. The Company operates in 32 countries around the world. Annual sales in 2008 were nearly $3.8 billion.

Forward-Looking Statements

This press release contains certain "forward-looking statements" within the meaning of the US Private Securities Litigation Reform Act of 1995. In particular, statements regarding expected revenue growth and trading margins discussed under "Outlook" are forward-looking statements as are discussions of our product pipeline. These statements, as well as the phrases "aim", "plan", "intend", "anticipate", "well-placed", "believe", "estimate", "expect", "target", "consider" and similar expressions, are generally intended to identify forward-looking statements. Such forward-looking statements involve known and unknown risks, uncertainties and other important factors (including, but not limited to, the outcome of litigation, claims and regulatory approvals) that could cause the actual results, performance or achievements of Smith & Nephew, or industry results, to differ materially from any future results, performance or achievements expressed or implied by such forward-looking statements. Please refer to the documents that Smith & Nephew has filed with the U.S. Securities and Exchange Commission under the U.S. Securities Exchange Act of 1934, as amended, including Smith & Nephew's most recent annual report on Form 20F, for a discussion of certain of these factors.

All forward-looking statements in this press release are based on information available to Smith & Nephew as of the date hereof. All written or oral forward-looking statements attributable to Smith & Nephew or any person acting on behalf of Smith & Nephew are expressly qualified in their entirety by the foregoing. Smith & Nephew does not undertake any obligation to update or revise any forward-looking statement contained herein to reflect any change in Smith & Nephew's expectation with regard thereto or any change in events, conditions or circumstances on which any such statement is based.


'/>"/>
SOURCE Smith & Nephew
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. RF Technologies Achieves Premier Certification From Cisco in United States
2. Caroline W. Nahas Named New Corporate Board Chair for United Way of Greater Los Angeles
3. United Spinal Associations 2009 Independence Expo Aug 7th-8th in Orlando: Improving Life for the Disabled and the Aging
4. Tampa Bay Doctor Agrees to Pay United States $1.7 Million to Resolve Medicare Fraud Allegations
5. Biopure Files Voluntary Petition for Relief Under Chapter 11 of the United States Bankruptcy Code
6. United American Nurses Hails House Health Care Reform Bill
7. United Physicians Goes Green Effective August 1st, 2009
8. Pelosi Statement on Appointment of Dr. Regina Benjamin as Surgeon General of the United States
9. iCRco Wins Government CR Contract with United States Coast Guard
10. Americans United for Life: Ninth Circuit Ruling on Pharmacists Endangers Fundamental Freedoms
11. Americans United for Life President to Testify at Sotomayor Senate Judiciary Hearing
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/28/2017)... (PRWEB) , ... April 28, 2017 , ... ... its new partnership with the Home Care Association of America (HCAOA). This agreement ... Private Duty Accreditation services, as well as discounts on Accreditation University (AU) educational ...
(Date:4/28/2017)... ... , ... Beginning in 2017, Ridgecrest Herbals will be phasing out the homeopathic ... Extra Strength formula. To ensure that the effectiveness of Clear Lungs Extra Strength is ... , Removal of the homeopathic element , Adding their patented ...
(Date:4/28/2017)... ... April 28, 2017 , ... GlycoMark, Inc. ... GlycoMark test throughout the Northeast U.S. , GlycoMark is the only clinically ... GlycoMark test provides a clinically proven one- to two-week measure of hyperglycemic excursions, ...
(Date:4/28/2017)... Fairfax, VA (PRWEB) , ... April 28, 2017 , ... ... elected volunteer board members and officers for 2017-2018. The annual board election process has ... serving on a volunteer basis. , Thomas C. Dickerson, Ed.D., FACHE, succeeds Jim Hamilton, ...
(Date:4/28/2017)... ... , ... The Texas Cord Blood Bank (TCBB), a program of nonprofit biomedical ... Women’s Hospital at Renaissance in Edinburg for their outstanding efforts in collecting umbilical cord ... donate. , “Women’s Hospital at Renaissance has been a collection partner for the ...
Breaking Medicine News(10 mins):
(Date:4/20/2017)... April 20, 2017   ZappRx, Inc ., a digital ... prescribing process, today announced it closed $25 million in Series ... capital firm based in Seattle that ... Partners . The Series B round included participation from ... 2014, and GV (formerly Google Ventures). As part ...
(Date:4/20/2017)... -- Eyevensys, a private biotechnology company developing ... technology that enables the safe, local, sustained production of ... range of ophthalmic diseases, announces it has received approval ... (MHRA) to advance its technology into clinical development. ... The EyeCET platform ...
(Date:4/19/2017)... - CRH Medical Corporation (TSX: CRH) (NYSE MKT: CRHM) (the "Company"), announces that ... Conference 2017 at the Sheraton Hotel in Toronto, Ontario ... of the Company is scheduled to present on Tuesday, May 2 ... the Chairman of the Board, Tony Holler will also ... For more ...
Breaking Medicine Technology: